Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ CaptureSelect™ CH1-XL Affinity Matrix
GREENER_CHOICE

Catalog No. 1943462250
Change view
Click to view available options
Quantity:
5 mL
10 mL
50 mL
250 mL
1 L
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
19-434-62250 250 mL
19-434-62005 5 mL
19-434-62010 10 mL
19-434-62050 50 mL
19-434-6201L 1 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
Catalog No. 19-434-62250 Supplier Thermo Scientific™ Supplier No. 1943462250
Only null left
Add to Cart
Add to Cart
Request a Quote

Thermo Scientific™ CaptureSelect™ CH1-XL Affinity Matrix is the improved version of CaptureSelect IgG-CH1 Affinity Matrix.

CaptureSelect CH1-XL Affinity Matrix is the improved version of CaptureSelect IgG-CH1 Affinity Matrix. The specificity is the same, but it features a wider elution range (pH 3.0-4.5), increased binding capacity, and improved stability at higher pH.

CaptureSelect CH1-XL Affinity Matrix recognizes the CH1 domain of human IgG antibodies, enabling purification of all subclasses (1, 2, 3, and 4) of human IgG and Fab fragments, independent of the light-chain isotype and source material.

CaptureSelect CH1-XL Affinity Matrix features include:

  • Platform approach for purification of IgGs and their Fab fragments directly from complex source materials in a single step with high purity and yield
  • Elution possible at pH 4.0–4.5 with 50 mM acetate buffer
  • No co-purification of overproduced free light chain due to selectivity for the CH1 domain
  • No binding to bovine antibodies, so presence of fetal bovine serum is not a problem
  • Excellent scalability
  • Non-animal derived

Free of animal components

CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).

Main characteristics:

  • Matrix: agarose-based, epoxide-activated
  • Average particle size: 65 ± 10 μm
  • Ligand: CaptureSelect CH1-XL affinity ligand
  • Ligand coupling method: epoxide coupling
  • Binding capacity: >15 mg/mL human Fab fragment depending on flow rate, column height, contact time. For humanized Fabs lower capacities can be observed.
  • Elution conditions: 100 mM glycine buffer, pH 3.0; 50 mM acetate buffer, pH 4.0–4.5
  • Flow rate: 50–200 cm/h (up to 2 bar)
  • Formulation buffer: 20% (v/v) ethanol

Specifications

Content And Storage Store at 2°C to 8°C.
Shipping Condition Approved for shipment at Room Temperature or on Wet Ice, Wet Ice
Stationary Phase Anti-IgG-CH1
Product Line CaptureSelect
Type Affinity Matrix
Quantity 250 mL
Form Agarose Bead
Particle Size 65 μm
Binding Capacity >15 mg/mL
Flow Rate 50 to 200 cm/hr. (Up to 2 bar)
Ligand Type CH1-XL affinity ligand
Matrix Agarose-based, epoxide-activated
Show More Show Less

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.